A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Blueprint Medicines Corporation
Blueprint Medicines Corporation
National Institutes of Health Clinical Center (CC)
Stanford University